Related references
Note: Only part of the references are listed.Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine
Shuji Ogino et al.
GUT (2018)
Aspirin Use and Reduced Risk of Pancreatic Cancer
Harvey A. Risch et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)
Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: US Preventive Services Task Force Recommendation Statement
Kirsten Bibbins-Domingo
ANNALS OF INTERNAL MEDICINE (2016)
The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine
Shuji Ogino et al.
EPIDEMIOLOGY (2016)
Population-wide Impact of Long-term Use of Aspirin and the Risk for Cancer
Yin Cao et al.
JAMA ONCOLOGY (2016)
Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies
Peter C. Austin et al.
STATISTICS IN MEDICINE (2015)
Estimates of benefits and harms of prophylactic use of aspirin in the general population
J. Cuzick et al.
ANNALS OF ONCOLOGY (2015)
Worth the Weight: Using Inverse Probability Weighted Cox Models in AIDS Research
Ashley L. Buchanan et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2014)
The association between low-dose aspirin use and the incidence of colorectal cancer: a nationwide cohort study
W-K Huang et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Aspirin for the Prevention of Cardiovascular Disease: U.S. Preventive Services Task Force Recommendation Statement
ANNALS OF INTERNAL MEDICINE (2013)
Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials
Peter M. Rothwell et al.
LANCET (2012)
Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials
Annemijn M. Algra et al.
LANCET ONCOLOGY (2012)
Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field
Shuji Ogino et al.
GUT (2011)
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial
John Burn et al.
LANCET (2011)
Lifestyle Factors and Microsatellite Instability in Colorectal Cancer: The Evolving Field of Molecular Pathological Epidemiology
Shuji Ogino et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials
Peter M. Rothwell et al.
LANCET (2010)
Aspirin for the Chemoprevention of Colorectal Adenomas: Meta-analysis of the Randomized Trials
Bernard F. Cole et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement
Jack Cuzick et al.
LANCET ONCOLOGY (2009)
The secret of immortal time bias in epidemiologic studies
Salimah Z. Shariff et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies
Enrico Flossmann et al.
LANCET (2007)
A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence
Eric J. Jacobs et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Low-dose aspirin in the primary prevention of cancer the women's health study: A randomized controlled trial
NR Cook et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
A randomized trial of aspirin to prevent colorectal adenomas
JA Baron et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Share Paper
